Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder

NCT02318602 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Seizures

Interventions

DRUG: Cannabidiol Oral Solution

Sponsor

INSYS Therapeutics Inc